Autoimmune markers in prognosis of Assisted Reproductive Technology efficiency

Authors

  • Galina Safarian St. Petersburg State Pediatric Medical University, 2, Litovskaya ul., St. Petersburg, 194100, Russian Federation
  • Lyailya Dzhemlikhanova D. O. Ott Research Institute for Obstetrics, Gynecology and Reproduction, 3, Mendeleevskaya liniya, St. Petersburg, 199034, Russian Federation ; St. Petersburg State University, 7–9, Universitetskaya nab., St. Petersburg, 199034, Russian Federation
  • Igor Kogan D. O. Ott Research Institute for Obstetrics, Gynecology and Reproduction, 3, Mendeleevskaya liniya, St. Petersburg, 199034, Russian Federation ; St. Petersburg State University, 7–9, Universitetskaya nab., St. Petersburg, 199034, Russian Federation
  • Darico Niauri 1 D. O. Ott Research Institute for Obstetrics, Gynecology and Reproduction, 3, Mendeleevskaya liniya, St. Petersburg, 199034, Russian Federation ; St. Petersburg State University, 7–9, Universitetskaya nab., St. Petersburg, 199034, Russian Federation
  • Olesya Bespalova Научно-исследовательский институт акушерства, гинекологии и репродуктологии им. Д. О. Отта, Российская Федерация, 199034, Санкт-Петербург, Менделеевская линия, 3 ; Санкт-Петербургский государственный университет, Российская Федерация, 199034, Санкт-Петербург, Университетская наб., 7–9
  • Alexander Gzgzyan D. O. Ott Research Institute for Obstetrics, Gynecology and Reproduction, 3, Mendeleevskaya liniya, St. Petersburg, 199034, Russian Federation ;St. Petersburg State University, 7–9, Universitetskaya nab., St. Petersburg, 199034, Russian Federation

DOI:

https://doi.org/10.21638/spbu11.2022.401

Abstract

According to reports, the efficiency of IVF/ICSI protocols is decreased in antithyroid antibodypositive patients as opposed to antibody negatives. However, there are opposite data indicating the absence of the antibody’s impact on the outcome of infertility treatment with assisted reproductive technologies. The prospective study enrolled 90 patients with infertility undergoing treatment with assisted reproductive technologies. The follicular fluid obtained on the day of oocyte retrieval was evaluated for antithyroid peroxidase and antithyroglobulin antibodies using commercial ELISA kits. The main group (n = 45) included women with verified autoimmune thyroiditis and measurable serum and follicular fluid levels of antithyroid antibodies. The comparison group was represented by 45 women without autoimmune thyroiditis. A reliably lower ovarian reserve parameters was noted in the study group relatively to the comparison group. It has been established that follicular fluid AT-TPO levels are negatively associated with the number of two-pronuclear zygotes. Moreover, the serum levels of AT-TPO ≥ 305,0 IU/ml are reliably associated with a higher frequency of suboptimal response to COS and lower clinical pregnancy rate in IVF (IVF/ICSI) cycles.

Keywords:

antibodies, AT-TPO, IVF/ICSI, suboptimal response, embryos, clinical pregnancy

Downloads

Download data is not yet available.
 

References

Литература

Kuharić M., Rozić D., Karner I. Thyroid Autoimmunity and Infertility // SEEMED. 2017. Vol. 1, no.

Ombelet W., Cooke I., Dyer S., Serour G., Devroey P. Infertility and the provision of infertility medical services in developing countries // Hum. Reprod. Update. 2008. Vol. 14, no. 6. P. 605–621.

Chen X., Mo M.-L., Huang C.-Y., Diao L.-H., Li G.-G., Li Yu.-Ye., Lerner A., Shoenfeld Y., Zeng Y.Association of serum autoantibodies with pregnancy outcome of patients undergoing first IVF/ICSI treatment: A prospective cohort study // J. Reprod. Immunol. 2017. Vol. 122. P. 14–20.

Перминова С. Г. Бесплодие у женщин с заболеваниями щитовидной железы: принципы диагностики, тактика ведения // Акушерство и гинекология: Новости. Мнения. Обучение. 2013.Т. 2. C. 18–24.

Фадеев В. В. По материалам клинических рекомендаций по диагностике и лечению заболеваний щитовидной железы во время беременности и в послеродовом периоде Американской тиреоидной ассоциации // Клиническая и экспериментальная тиреоидология. 2012. Т. 8, № 1. C. 7–18.

Сафарян Г. Х., Гзгзян А. М., Джемлиханова Л. Х., Ниаури Д. А. Результативность протоколов ЭКО/ИКСИ у женщин с субклиническим гипотиреозом и носительством антител к щитовидной железе // Журнал акушерства и женских болезней. 2019. Т. 68, № 4. C. 83–94.

Poppe K., Autin C., Veltri F., Kleynen P., Grabczan L., Rosenberg S., Ameye L. Thyroid Autoimmunity and ICSI Pregnancy // J. Clin. Endocrinol. Metab. 2018. Vol. 103, no. 5. P. 1755–1766.

Vissenberg R., Manders U. D., Mastenbroek S., Fliers E., Afink G. B., Ris-Stalpers C., Goddijn M., Bisschop P. H. Pathophysiological aspects of thyroid hormone disorder/thyroid peroxidase autoantibodies and reproduction // Hum. Reprod. Update. 2015. Vol. 21, no. 3. P. 378- 387.

Cline A., Kutteh W. Is there a role of autoimmunity in implantation failure after in-vitro fertilization?// Curr. Opin. Obstet. Gynecol. 2009. Vol. 21. P. 291–295.

Monteleone P., Parrini D., Faviana P., Carletti E., Casarosa E., Uccelli A., Cela V., Genazzani A. R.,Artini P. G. Female infertility related to thyroid autoimmunity: the ovarian follicle hypothesis // Am. J. Reprod. Immunol. 2011. Vol. 66, no. 2. P. 108–114.

Weghofer A., Himaya E., Kushnir V. A., Barad D. H., Gleicher N. The impact of thyroid function and thyroid autoimmunity on embryo quality in women with low functional ovarian reserve: a casecontrol study // Reprod. Biol. Endocrinol. 2015. Vol. 13, no. 1. P. 43–49.

Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting // Hum. Reprod. 2011. Vol. 26, no. 6. P. 1270–1283.

Tao J., Tamis R., Fink K., Williams B., Nelson-White T., Craig R. The neglected morula/compact stage embryo transfer // Hum. Reprod. 2002. Vol. 17, no. 6. P. 1513–1518.

Gardner D. K., Sakkas D. Assessment of embryo viability: the ability to select a single embryo for transfer — a review // Placenta. 2003. Vol. 24. P. 5–12.

Farquhar C., Marjoribanks J. Assisted reproductive technology: an overview of Cochrane Reviews // Cochrane Database Syst. Rev. 2018. Vol. 8, no. 8. P. CD010537

Zhong Y., Ying Y., Wu H., Zhou C., Xu Y., Wang Q., Li J., Shen X., Li J. Relationship between Antithyroid Antibody and Pregnancy Outcome following in Vitro Fertilization and Embryo Transfer // Int. J. Med. Sci. 2012. Vol. 9. P. 121–125.

Medenica S., Garalejia E., Arsic B., Medjo B., Bojovic Jovic D., Abazovic D., Vukovic R., Zarkovic M.Follicular fluid thyroid autoantibodies, thyrotropin, free thyroxine levels and assisted reproductive technology outcome // PLoS ONE. 2018. Vol. 13, no. 10. P. e0206652.

Miko E., Meggyes M., Doba K., Farkas N., Bogar B., Barakonyi A., Szereday L., Szekeres-Bartho J., Mezosi E. Characteristics of peripheral blood NK and NKT-like cells in euthyroid and hypothyroid women with autoimmunity, experiencing reproductive failure // J. Reprod. Immunol. 2017. Vol. 124. P. 62–70.

Sokolov D. I., Mikhailova V. A., Agnayeva A. O., Bazhenov D. O., Khokhlova E. V., Bespalova O. N., Gzgzyan A. M., Selkov S. A. NK and trophoblast cells interaction: cytotoxic activity on recurrent pregnancy loss // Gynecol. Endocrinol. 2019. Vol. 35, no. 1. P. 5–10.


References

Kuharić M., Rozić D., Karner I. Thyroid Autoimmunity and Infertility. SEEMEDJ, 2017, vol. 1, no. 2, pp. 1–10.

Ombelet W., Cooke I., Dyer S., Serour G., Devroey P. Infertility and the provision of infertility medical services in developing countries. Hum. Reprod. Update, 2008, vol. 14, no. 6, pp. 605–621.

Chen X., Mo M.-L., Huang C.-Y., Diao L.-H., Li G.-G., Li Yu.-Ye., Lerner A., Shoenfeld Y., Zeng Y. Association of serum autoantibodies with pregnancy outcome of patients undergoing first IVF/ICSI treatment: A prospective cohort study. J. Reprod. Immunol., 2017, vol. 122, pp. 14–20.

Perminova S. G. Infertility in women with thyroid disease: Principles of diagnosis, management.Akusherstvo i ginekologiia: Novosti. Mneniia. Obuchenie, 2013, no. 2, pp. 18–24. (In Russian)

Fadeev V. V. According to the clinical recommendations of American thyroid association in thyroid pathology diagnosis and treatment during pregnancy and postpartum. Clinical and experimental thyroidology, 2012, vol. 1, no. 8, pp. 7–18. (In Russian)

Safaryan G. Kh., Gzgzyan A. M., Dzhemlikhanova L. Kh., Niauri D. A. The efficiency of IVF/ICSI protocols in female with subclinical hypothyroidism and thyroid autoimmunity.Journal of Obstetrics and Women’s Diseases, 2019, vol. 68, no. 4, pp. 83–94.

Poppe K., Autin C., Veltri F., Kleynen P., Grabczan L., Rosenberg S., Ameye L.Thyroid Autoimmunity and ICSI Pregnancy // J. Clin. Endocrinol. Metab. 2018. Vol. 103, no. 5. P. 1755–1766.

Vissenberg R., Manders U. D., Mastenbroek S., Fliers E., Afink G. B., Ris-Stalpers C., Goddijn M., Bisschop P. H. Pathophysiological aspects of thyroid hormone disorder/thyroid peroxidase autoantibodies and reproduction // Hum. Reprod. Update. 2015. Vol. 21, no. 3. P. 378- 387.

Cline A., Kutteh W.Is there a role of autoimmunity in implantation failure after in-vitro fertilization?// Curr. Opin. Obstet. Gynecol. 2009. Vol. 21. P. 291–295.

Monteleone P., Parrini D., Faviana P., Carletti E., Casarosa E., Uccelli A., Cela V., Genazzani A. R.,Artini P. G.Female infertility related to thyroid autoimmunity: the ovarian follicle hypothesis // Am. J. Reprod. Immunol. 2011. Vol. 66, no. 2. P. 108–114.

Weghofer A., Himaya E., Kushnir V. A., Barad D. H., Gleicher N. The impact of thyroid function and thyroid autoimmunity on embryo quality in women with low functional ovarian reserve: a casecontrol study // Reprod. Biol. Endocrinol. 2015. Vol. 13, no. 1. P. 43–49.

Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting // Hum. Reprod. 2011. Vol. 26, no. 6. P. 1270–1283.

Tao J., Tamis R., Fink K., Williams B., Nelson-White T., Craig R. The neglected morula/compact stage embryo transfer // Hum. Reprod. 2002. Vol. 17, no. 6. P. 1513–1518.

Gardner D. K., Sakkas D. Assessment of embryo viability: the ability to select a single embryo for transfer — a review // Placenta. 2003. Vol. 24. P. 5–12.

Farquhar C., Marjoribanks J. Assisted reproductive technology: an overview of Cochrane Reviews // Cochrane Database Syst. Rev. 2018. Vol. 8, no. 8. P. CD010537

Zhong Y., Ying Y., Wu H., Zhou C., Xu Y., Wang Q., Li J., Shen X., Li J.Relationship between Antithyroid Antibody and Pregnancy Outcome following in Vitro Fertilization and Embryo Transfer // Int. J. Med. Sci. 2012. Vol. 9. P. 121–125.

Medenica S., Garalejia E., Arsic B., Medjo B., Bojovic Jovic D., Abazovic D., Vukovic R., Zarkovic M.Follicular fluid thyroid autoantibodies, thyrotropin, free thyroxine levels and assisted reproductive technology outcome // PLoS ONE. 2018. Vol. 13, no. 10. P. e0206652.

Miko E., Meggyes M., Doba K., Farkas N., Bogar B., Barakonyi A., Szereday L., Szekeres-Bartho J., Mezosi E. Characteristics of peripheral blood NK and NKT-like cells in euthyroid and hypothyroid women with autoimmunity, experiencing reproductive failure // J. Reprod. Immunol. 2017. Vol. 124. P. 62–70.

Sokolov D. I., Mikhailova V. A., Agnayeva A. O., Bazhenov D. O., Khokhlova E. V., Bespalova O. N., Gzgzyan A. M., Selkov S. A. NK and trophoblast cells interaction: cytotoxic activity on recurrent pregnancy loss // Gynecol. Endocrinol. 2019. Vol. 35, no. 1. P. 5–10.

Published

2023-05-31

How to Cite

Safarian, G. ., Dzhemlikhanova, L. ., Kogan, I. ., Niauri, D. ., Bespalova , O. ., & Gzgzyan, A. (2023). Autoimmune markers in prognosis of Assisted Reproductive Technology efficiency. Vestnik of Saint Petersburg University. Medicine, 17(4), 238–253. https://doi.org/10.21638/spbu11.2022.401

Issue

Section

Obstetrics and ginecology

Most read articles by the same author(s)